HEUKING Advised G. Heinemann Medizintechnik On SHS Capital’s Entry Into Its Endoscopy Group

HEUKING advised G. Heinemann Medizintechnik on SHS Capital’s entry into its endoscopy group

HEUKING advised G. Heinemann Medizintechnik GmbH comprehensively on SHS Capital’s acquisition of a minority interest in its endoscopy group and supported the transaction. The endoscopy group comprises EMOS Technology GmbH, Innoview GmbH, ILO electronic GmbH, and Micon Medizintechnik GmbH. Closing is expected shortly.

HEUKING’s mandate included support throughout the due diligence process as well as drafting and negotiating the transaction documentation. Based in Kaltenkirchen, G. Heinemann Medizintechnik GmbH has been manufacturing and distributing ENT treatment units and ENT diagnostic devices since 1983. The companies in the endoscopy group develop and manufacture high-quality, innovative, reusable endoscopes, as well as camera and lighting systems and insufflators for a range of medical applications. Key production steps are carried out in Germany at the Illmensee, Kaltenkirchen, and Eichstetten sites. The group’s customers include international OEMs and distributors across Europe, North America, Latin America, and Asia.

SHS Capital, based in Tübingen, is a German private equity investor focusing on innovative healthcare companies and has been active in the sector since 1993. The investment in the endoscopy group is being made from SHS’s sixth fund, launched in 2022, with a volume of about EUR 270 million.

The HEUKING team led by Dr. Alexander Schott (Salaried Partner) regularly advised G. Heinemann Medizintechnik GmbH and the companies in the endoscopy group on a range of legal matters.

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.